๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of sublingual apomorphine in idiopathic Parkinson's disease

โœ Scribed by F. Durif; F. Serre; D. Deffond; A. Eschalier; M. Tournilhac

Book ID
115885260
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
220 KB
Volume
183
Category
Article
ISSN
0014-2999

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A novel sublingual apomorphine treatment
A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease
โœ William Ondo; Christine Hunter; Michael Almaguer; Joseph Jankovic ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 2 views

We tested a novel preparation of a sublingual apomorphine hydrochloride tablet (APO) in 10 patients with advanced Parkinson's disease complicated by motor fluctuations. After a dose titration, patients took either 40 mg APO three times per day alternating with levodopa doses (eight patients) or six

A new sublingual formulation of apomorph
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
โœ Dr. T. van Laar; C. Neef; M. Danhof; K. I. Roon; R. A. C. Roos ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 503 KB

## Abstract A new formulation of a sublingual tablet with 10 mg apomorphine was examined in 13 patients with Parkinson's disease. Vitamin C (250 mg) was added sublingually to lower the salivary pH. Four patients received sublingual apomorphine and nine received sublingual apomorphine as well as vit